← Aurinia Pharmaceuticals Inc. AUPH
Market Price
$15.47
Market Cap
$1.95B
P/E Ratio
7.48
Revenue (FY 2025)
↑20.4% YoY
$283.06M
3-Yr CAGR: 28.3%
Net Income
↑4,893.1% YoY
$287.20M
Net Margin: 101.5%
Free Cash Flow
↑207.0% YoY
$135.41M
FCF Yield: 6.93%
EPS (Diluted)
↑5,075.0% YoY
$2.07
Basic: $2.14
Return on Equity
Efficiency
49.4%
ROA: 58.4%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (AUPH)
All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
- FY 2017: Revenue YoY (+142.8%) is identical to Gross Profit YoY (+142.8%). Verify the underlying Revenue and Gross Profit values for FY 2017 and FY 2016.
- FY 2018: Revenue YoY (+10.2%) is identical to Gross Profit YoY (+10.2%). Verify the underlying Revenue and Gross Profit values for FY 2018 and FY 2017.
| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $0.2M | — | $0.2M | $-25.0M | — | $-0.66 | — | $-18.7M | — | — |
| FY 2017 | $0.4M | +142.8% | $0.4M | $-46.9M | -87.3% | $-0.92 | -39.4% | $-41.2M | $-41.2M | — |
| FY 2018 | $0.5M | +10.2% | $0.4M | $-64.0M | -36.7% | $-0.76 | +17.4% | $-51.6M | $-51.6M | -25.4% |
| FY 2019 | $0.3M | -31.3% | $0.3M | $-123.7M | -93.1% | $-1.33 | -75.0% | $-63.5M | $-63.5M | -23.0% |
| FY 2020 | $50.1M | +15,660.4% | $44.2M | $-102.7M | +17.0% | — | — | $-69.9M | — | — |
| FY 2021 | $45.6M | -9.0% | $44.5M | $-181.0M | -76.2% | $-1.40 | — | $-157.7M | $-157.7M | — |
| FY 2022 | $134.0M | +193.9% | $128.4M | $-108.2M | +40.2% | $-0.76 | +45.7% | $-79.5M | $-79.5M | +49.6% |
| FY 2023 | $175.5M | +31.0% | $161.4M | $-78.0M | +27.9% | $-0.54 | +28.9% | $-33.5M | $-34.2M | +57.0% |
| FY 2024 | $235.1M | +34.0% | $206.9M | $5.8M | +107.4% | $0.04 | +107.4% | $44.4M | $44.1M | +229.0% |
| FY 2025 | $283.1M | +20.4% | $250.4M | $287.2M | +4,893.1% | $2.07 | +5,075.0% | $135.7M | $135.4M | +207.0% |
Valuation
Market Price
$15.47
Market Cap
$1.95B
Enterprise Value
N/A
P/E Ratio
7.48
P/B Ratio
3.42
FCF Yield
6.93%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
88.46%
Operating Margin
37.06%
Net Margin
101.47%
Return on Equity (ROE)
49.40%
Return on Assets (ROA)
58.38%
Asset Turnover
0.58x
Revenue 3-Yr CAGR
28.30%
Financial Health & Liquidity
Current Ratio
7.38
Cash Ratio
1.20
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$80.16M
Total Debt
N/A
Book Value / Share
$4.52
Cash Flow Efficiency
Operating Cash Flow
$135.66M
Capital Expenditures (CapEx)
$252.00K
Free Cash Flow
$135.41M
OCF / Revenue
47.93%
FCF / Revenue
47.84%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$2.07
EPS (Basic)
$2.14
Dividends / Share
N/A
Book Value / Share
$4.52
EPS YoY Growth
5,075.00%
Balance Sheet (FY 2025)
Total Assets
$491.97M
Total Liabilities
$66.62M
Stockholders' Equity
$581.33M
Current Assets
$491.97M
Current Liabilities
$66.62M